Every conversation I have with enterprise leaders today carries an unmistakable urgency about AI transformation. The economics have changed, possibilities have expanded dramatically, and the pressure ...

The following is a news release from the Idaho Attorney General's Office: BOISE, Idaho — On February 2, 2026, Attorney General Labrador joined a coalition of 48 states and territories announcing ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

Oklahomans who purchased certain generic prescription drugs between 2009 and 2019 may be eligible for compensation after two pharmaceutical companies agreed to pay $17.85 million to settle allegations ...

Novartis NOVN1.31%increase; green up pointing triangle said it expected a key profitability metric to decline this year in large part due to increased competition in the U.S. from generic drug ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Novo Nordisk A/S (NYSE: NVO) is accused of unlawfully extending its monopoly over its diabetes drug Victoza through a multiyear anticompetitive scheme designed to delay generic competition. • What’s ...

Microsoft and Linux are adding AI and Rust to their pipelines. Microsoft is leaning much harder into AI development than Linux. Both are expanding Rust, but neither OS will be fully Rust soon.

The adoption rate of AI tools has skyrocketed in the programming world, enabling coders to generate vast amounts of code with simple text prompts. Earlier this year, Google found that 90 percent of ...

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...

The tablets are indicated for the treatment of moderate to severe vasomotor symptoms due to menopause. Dultra added, "We are proud to continue our mission of delivering high-quality, affordable ...